Foster James Alexander Cunliffe - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-29
5:16 pm
Purchase
2025-03-3113GVIRAX BIOLABS GROUP LTD SHS NE
VRAX
Foster James Alexander Cunliffe14,743
8.300%
1,945increase
(+15.20%)
Filing
History
2025-10-29
5:16 pm
Purchase
2024-09-3013GVIRAX BIOLABS GROUP LTD SHS NE
VRAX
Foster James Alexander Cunliffe12,798
7.300%
1,279increase
(+11.10%)
Filing
History
2025-10-29
5:11 pm
Unchanged
2023-12-3113GVIRAX BIOLABS GROUP LTD SHS NE
VRAX
Foster James Alexander Cunliffe11,519
12.900%
0
(Unchanged)
Filing
History
2025-10-29
5:09 pm
Purchase
2022-12-3113GVIRAX BIOLABS GROUP LTD SHS NE
VRAX
Foster James Alexander Cunliffe11,519
24.900%
11,519increase
(New Position)
Filing
History